Results 261 to 270 of about 54,430 (317)

Blood-borne vasodilating agent from ischemic tissues

Journal of Applied Physiology, 1960
Plethysmographic measurements of forearm blood flow show a drop to minimal values immediately after release of arterial occlusion of a leg; this is soon followed by a somewhat greater and more sustained increase to values above the control. Prepacking the leg with blood before arterial occlusion, or exercise before occlusion, or a combination of these
B R, FREEBURG, C, HYMAN
openaire   +2 more sources

Pharmacokinetics of Vasodilating Agents

1986
Studies on the metabolism of nitroglycerin in various animal species have shown distinct differences making it problematic to extrapolate from experimental animal data to humans. Needleman et al. (1972) found complete inactivation of nitrates following oral administration in rats as a result of the first-pass effect in the liver.
openaire   +1 more source

The Effect of Local Vasodilating Agents

1977
Contrary to the previously widely held concept that nitroglycerin is contraindicated in acute myocardial infarction, it has recently been shown that the administration of nitroglycerin to patients with acute myocardial infarction and elevated left ventricular filling pressures results in a reduction in filling pressure and in an increase in cardiac ...
openaire   +2 more sources

Vasodilators (Other Agents and Drug Classes)

2000
In addition to the angiotensin II receptor blockers, the angiotensin converting enzyme inhibitors, and the calcium channel blockers, which are discussed in other chapters, there are other peripheral vasodilators that include a wide variety of compounds with highly disparate mechanisms of action.
William H. Frishman, Angela Cheng-Lai, Julie Chen   +2 more
openaire   +1 more source

Chapter 8. Vasodilator and Vasoconstrictor Agents

1969
Publisher Summary This chapter presents an overview of vasodilator and vasoconstrictor agents. Many drugs with diverse pharmacological actions ultimately alter vascular tone. Antihypertensive agents as well as drugs used to treat peripheral vascular diseases are among those that reduce vascular tone.
F.P. Hauck, C.N. Gillis
openaire   +1 more source

Vasodilator agents protect against indinavir nephrotoxicity.

Antiviral therapy, 2004
Indinavir (IDV) is a protease inhibitor widely used in AIDS treatment. A sustained elevation of creatinine was identified in IDV-treated patients. We have previously demonstrated that IDV causes renal vasoconstriction in rats. The objective of this study was to investigate the mechanism of IDV-induced vasoconstriction and the effect that the ...
Mogali, de Araujo, Antonio Carlos, Seguro   +1 more
openaire   +1 more source

Mechanism of Action of Vasodilating Agents

1988
The development of heart failure is accompanied by the activation of neuroendocrine compensatory mechanisms (see chapter “Endocrine response to heart failure”). Although these responses are initially aimed at preserving cardiovascular homeostasis, they eventually lead to a further deterioration of myocardial performance due to excessive ...
J. Biollaz, A. Munafo, T. Buclin
openaire   +1 more source

Molecular imaging in oncology: Current impact and future directions

Ca-A Cancer Journal for Clinicians, 2022
Steven P Rowe, Martin G Pomper
exaly  

Treatment of muscle‐invasive and advanced bladder cancer in 2020

Ca-A Cancer Journal for Clinicians, 2020
Vaibhav G Patel, William K Oh, Matthew D Galsky   +2 more
exaly  

Vasodilator Antianginal Agents

Drug Information Journal, 1976
openaire   +1 more source